Diagnostics and Tools stocks tracked biotech stocks during the huge moves in January/February and sold off until the April bottom. However stocks that are more revenue and earnings driven -Cardiovascular Systems(CSII) and Quidel (QDEL)- did not recover to former highs. Sequenom (SQNM) is a leader in non-invasive pre-natal tests such as their Materni T21 test for women at risk.
The complete universe of Dx and Tools stocks we track including financial metrics are here.
- Our top pick order priligy priligy Illumina (ILMN) is up 65% YTD.
- Other top winners YTD: Sequenom (SQNM) up 66.2%, Exact Sciences (EXAS) up 46.6%, Pacific Biosciences (PACB) up 21.4% and Hologic (HOLX) up 15.4%.
- Top losers YTD: Quidel (QDEL) down 29%, Nanostring Technologies (NSTG) down 14.4% and Cardiovascular Systems (CSII) down 7.2%. All of these stocks hit their highs in Q1 when many life science stocks peaked.
For complete list of all Rayno Dx and Tools picks see Seeking Alpha.